Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jul;19(7):658-64.

Metformin: Current knowledge

Hamid Nasri  1 , Mahmoud Rafieian-Kopaei  2
Affiliations
Review

Metformin: Current knowledge

Hamid Nasri et al. J Res Med Sci. 2014 Jul.

Erratum in

  • Erratum: Metformin: Current knowledge.
    [No authors listed] [No authors listed] J Res Med Sci. 2024 Jan 30;29:6. doi: 10.4103/JRMS.JRMS_62_24. eCollection 2024. J Res Med Sci. 2024. PMID: 38524744 Free PMC article.

Abstract

Diabetes mellitus is a group of metabolic disorders in which the blood glucose is higher than normal levels, due to insufficiency of insulin release or improper response of cells to insulin, resulting in high blood pressure. The resultant hyperglycemia produces sever complications. Metformin drug has been shown to prevent diabetes in people who are at high risk and decrease most of the diabetic complications. Recent reports on metformin, not only indicate some implications such as renoprotective properties have been suggested for metformin, but some reports indicate its adverse effects as well that are negligible when its benefits are brought into account. We aimed here to review the new implications of metformin and discuss about the concerns in the use of metformin, referring to the recently published papers.

Keywords: Diabetes; diabetes mellitus; diabetic nephropathy; glucose; metformin; new applications; polycystic ovary syndrome; renoprotection.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Scheen AJ, Paquot N. Metformin revisited: A critical review of the benefit-risk balance in at-risk patients with type 2 diabetes. Diabetes Metab. 2013;39:179–90. - PubMed
    1. Kirpichnikov D, McFarlane SI, Sowers JR. Metformin: An update. Ann Intern Med. 2002;137:25–33. - PubMed
    1. Hundal RS, Inzucchi SE. Metformin: New understandings, new uses. Drugs. 2003;63:1879–94. - PubMed
    1. Scarpello JH, Howlett HC. Metformin therapy and clinical uses. Diab Vasc Dis Res. 2008;5:157–67. - PubMed
    1. Rafieian-Kopaei M, Baradaran A. Combination of metformin with other antioxidants may increase its renoprotective efficacy. J Ren Inj Prev. 2013;2:35–6. - PMC - PubMed

LinkOut - more resources